CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | ZELDIS JEROME B Director | Option exercise 10b5-1 | +12,000 | $30.86 | $370K | 26,500 |
| 2024-12-02 | ZELDIS JEROME B Director | Sale 10b5-1 | −5,699 | $50.52 | $288K | 20,801 |
| 2024-12-02 | ZELDIS JEROME B Director | Sale 10b5-1 | −2,634 | $51.43 | $135K | 18,167 |
| 2024-12-02 | ZELDIS JEROME B Director | Sale 10b5-1 | −3,667 | $52.39 | $192K | 14,500 |
| 2024-12-02 | ZELDIS JEROME B Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 0 | ||
| 2024-12-02 | ZELDIS JEROME B Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 0 | ||
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +3,105 | $51.00 | $158K | 55,533 |
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −2,497 | $51.34 | $128K | 53,036 |
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −608 | $52.24 | $32K | 52,428 |
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +14,695 | $51.00 | $749K | 67,123 |
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9,919 | $51.53 | $511K | 57,204 |
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −4,776 | $52.45 | $251K | 52,428 |
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,105 | 14,695 | ||
| 2024-12-02 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −14,695 | 0 | ||
| 2024-12-02 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +1,960 | $51.00 | $100K | 94,349 |
| 2024-12-02 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,960 | $52.17 | $102K | 92,389 |
| 2024-12-02 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +83,640 | $51.00 | $4.3M | 176,029 |
| 2024-12-02 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −83,640 | $52.26 | $4.4M | 92,389 |
| 2024-12-02 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,960 | 83,640 | ||
| 2024-12-02 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −83,640 | 0 |
Page 32 of 41 · 804 trades